These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34162453)

  • 21. A novel variant in RyR2 causes familiar catecholaminergic polymorphic ventricular tachycardia.
    Bosch C; Campuzano O; Sarquella-Brugada G; Cesar S; Perez-Serra A; Coll M; Mademont I; Mates J; Del Olmo B; Iglesias A; Brugada J; Petersen V; Brugada R
    Forensic Sci Int; 2017 Jan; 270():173-177. PubMed ID: 27988446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catecholaminergic polymorphic ventricular tachycardia. An important diagnosis in children with syncope and normal heart.
    Leite LR; Ponzi Pereira KR; Alessi SR; de Paola AA
    Arq Bras Cardiol; 2001 Jan; 76(1):63-74. PubMed ID: 11175485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ventricular tachycardia recorded in a competitive swimmer using Confirm Rx™ loop recorder.
    Yoon JG; Snyder CS; Hoyt WJ
    Cardiol Young; 2020 Mar; 30(3):438-440. PubMed ID: 32036810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolution of clinical diagnosis in patients presenting with unexplained cardiac arrest or syncope due to polymorphic ventricular tachycardia.
    Vittoria Matassini M; Krahn AD; Gardner M; Champagne J; Sanatani S; Birnie DH; Gollob MH; Chauhan V; Simpson CS; Hamilton RM; Talajic M; Ahmad K; Gerull B; Chakrabarti S; Healey JS
    Heart Rhythm; 2014 Feb; 11(2):274-81. PubMed ID: 24239842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catecholaminergic polymorphic ventricular tachycardia in a child: a case report.
    Garabedian L; Verryckt A; Panzer J; De Wolf D
    Acta Paediatr; 2008 Jan; 97(1):127-9. PubMed ID: 18052993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transtelephonic monitoring and transmission of stored arrhythmia detection and therapy data from an implantable cardioverter defibrillator.
    Fetter JG; Stanton MS; Benditt DG; Trusty J; Collins J
    Pacing Clin Electrophysiol; 1995 Aug; 18(8):1531-9. PubMed ID: 7479174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical usefulness of implantable loop recorder in diagnosis of unexplained syncope--case report].
    Stec S; Makowska E; Kułakowski P
    Kardiol Pol; 2005 Apr; 62(4):376-80; discussion 380. PubMed ID: 15928742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dizziness and syncope in young people: keep your mind open! Case report of the challenging differentiation between arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) and catecholaminergic polymorphic ventricular tachycardia (CPVT).
    Comelli I; Gonzi G; Mossini G; Lippi G; Meschi T; Borghi L; Cervellin G
    Acta Biomed; 2014 May; 85(1):73-80. PubMed ID: 24897975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia.
    Sy RW; Gollob MH; Klein GJ; Yee R; Skanes AC; Gula LJ; Leong-Sit P; Gow RM; Green MS; Birnie DH; Krahn AD
    Heart Rhythm; 2011 Jun; 8(6):864-71. PubMed ID: 21315846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful radiofrequency catheter ablation of idiopathic ventricular fibrillation presented as recurrent syncope and diagnosed by an implanted loop recorder.
    Yu CC; Tsai CT; Lai LP; Lin JL
    Int J Cardiol; 2006 Jun; 110(1):112-3. PubMed ID: 16019089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catecholaminergic polymorphic ventricular tachycardia managed as orthostatic dysregulation and epilepsy in 11- and 15-year-old sisters.
    Fujita S; Nishida K; Irabu H; Nakagawa R; Futatani T; Igarashi N; Usuda K; Nagata Y; Ohno S; Horie M; Hatasaki K
    Pediatr Int; 2018 Nov; 60(11):998-1001. PubMed ID: 30157307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ablation of a catecholaminergic polymorphic VT and VF originating from Purkinje fibers--a case report].
    Szumowski L; Walczak F; Przybylski A; Maryniak A; Szufladowicz E; Derejko P; Bieganowska K; Bodalski R; Orczykowski M; Sterliński M; Miszczak-Knecht M; Szwed A
    Kardiol Pol; 2007 Mar; 65(3):319-26. PubMed ID: 17436165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical experiences of patients with catecholaminergic polymorphic ventricular tachycardia.
    Celiker A; Erdoğan I; Karagöz T; Ozer S
    Cardiol Young; 2009 Feb; 19(1):45-52. PubMed ID: 19102802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence that nonsustained polymorphic ventricular tachycardia causes syncope (data from implantable cardioverter defibrillators).
    Farmer DM; Swygman CA; Wang PJ; Mark Estes NA; Link MS
    Am J Cardiol; 2003 Mar; 91(5):606-9. PubMed ID: 12615273
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of implantable loop recorders in patients with Brugada syndrome and suspected risk of ventricular arrhythmia.
    Kubala M; Aïssou L; Traullé S; Gugenheim AL; Hermida JS
    Europace; 2012 Jun; 14(6):898-902. PubMed ID: 21979995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catecholaminergic polymorphic ventricular tachycardia with associated sinus node dysfunction.
    Joshi P; Saxena A; Kaul U; Mansoor AH
    Indian Heart J; 2010; 62(1):84-6. PubMed ID: 21180045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive value of presyncope in patients monitored for assessment of syncope.
    Krahn AD; Klein GJ; Yee R; Skanes AC;
    Am Heart J; 2001 May; 141(5):817-21. PubMed ID: 11320372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Red Flags in Syncope: Clues for the Diagnosis of Idiopathic Ventricular Fibrillation.
    Belhassen B; Tovia-Brodie O
    Am J Med; 2022 Dec; 135(12):1434-1436. PubMed ID: 35878689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate.
    Miyake CY; Webster G; Czosek RJ; Kantoch MJ; Dubin AM; Avasarala K; Atallah J
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):579-87. PubMed ID: 23667268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.